erythromycin

FDA Drug Profile — erythromycin

erythromycin is listed in the FDA National Drug Code directory with 9 NDC codes, marketed under brand name including erythromycin. Available dosage forms: solution, ointment, capsule, delayed release pellets, powder.

Drug details

Generic Name
erythromycin
Brand Names
erythromycin
Application Number
ANDA063038
Sponsor
Bryant Ranch Prepack
NDC Codes
9
Dosage Forms
SOLUTION, OINTMENT, CAPSULE, DELAYED RELEASE PELLETS, POWDER
Routes
TOPICAL, OPHTHALMIC, ORAL
Active Ingredients
ERYTHROMYCIN

Indications and Usage

INDICATIONS AND USAGE For the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by organisms susceptible to erythromycin. For prophylaxis of ophthalmia neonatorum due to N. gonorrhoeae or C. trachomatis . The effectiveness of erythromycin in the prevention of ophthalmia caused by penicillinase-producing N. gonorrhoeae is not established. For infants born to mothers with clinically apparent gonorrhea, intravenous or intramuscular injections of aqueous crystalline penicillin G should be given: a single dose of 50,000 units for term infants or 20,000 units for infants of low birth weight. Topical prophylaxis alone is inadequate for these infants.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.